We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+9.73%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$492B
AUM Growth
+$21.5B
Cap. Flow
-$6.18B
Cap. Flow %
-1.26%
Top 10 Hldgs %
30.05%
Holding
13,811
New
1,371
Increased
4,862
Reduced
5,559
Closed
1,866

Sector Composition

Rank Sector Weight
1 Miscellaneous 90.23%
2 Technology 2.7%
3 Consumer Discretionary 1.66%
4 Financials 1.18%
5 Communication Services 1.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HYMC icon
11326
PUT
Hycroft Mining Holding Corp
HYMC
$2.48B
$44.8K ﹤0.01%
14,940
+5,570
+59% +$21.1K
SDIG
11327
PUT
DELISTED
Stronghold Digital Mining, Inc. Class A Common Stock
SDIG
$44.7K ﹤0.01%
10,700
+9,670
+939% +$66.8K
TRVI icon
11328
CALL
Trevi Therapeutics
TRVI
$2.55B
$44.7K ﹤0.01%
+18,700
New +$47.1K
LFWD icon
11329
ReWalk Robotics
LFWD
$21.5M
$44.6K ﹤0.01%
+886
New +$46.2K
DRIO icon
11330
DarioHealth
DRIO
$69.1M
$44.5K ﹤0.01%
555
-2,463
-82% -$187K
NUTX
11331
Nutex Health
NUTX
$1.32B
$44.4K ﹤0.01%
702
+2
+0.3% +$172
UBX
11332
PUT
DELISTED
Unity Biotechnology
UBX
$44.1K ﹤0.01%
17,300
+5,700
+49% +$15.1K
DMAC icon
11333
CALL
DiaMedica Therapeutics
DMAC
$356M
$44.1K ﹤0.01%
+10,200
New +$24.8K
CURV icon
11334
Torrid Holdings
CURV
$220M
$44.1K ﹤0.01%
+15,679
New +$50.1K
CKPT
11335
DELISTED
Checkpoint Therapeutics
CKPT
$43.9K ﹤0.01%
17,785
+7,340
+70% +$20K
AGIG
11336
CALL
Abundia Global Impact Group
AGIG
$45M
$43.9K ﹤0.01%
2,060
-2,530
-55% -$59K
HYZN
11337
PUT
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
$43.9K ﹤0.01%
+914
New +$33.5K
MMLP icon
11338
Martin Midstream Partners
MMLP
$88.8M
$43.8K ﹤0.01%
20,582
-9,310
-31% -$22.1K
HERZ
11339
Herzfeld Credit Income Fund
HERZ
$32.4M
$43.8K ﹤0.01%
+1,305
New +$41.3K
SACH
11340
PUT
Sachem Capital Corp
SACH
$42.7M
$43.3K ﹤0.01%
+12,400
New +$41.9K
CYPH
11341
CALL
Cypherpunk Technologies Inc
CYPH
$211M
$43.2K ﹤0.01%
+13,800
New +$69.3K
PPBT
11342
CALL
Purple Biotech
PPBT
$2.73M
$43.1K ﹤0.01%
154
+8
+5% +$2.87K
OSS icon
11343
CALL
One Stop Systems
OSS
$283M
$43K ﹤0.01%
+15,000
New +$39.7K
ICAD
11344
DELISTED
iCAD Inc
ICAD
$42.6K ﹤0.01%
+26,142
New +$35K
ASXC
11345
DELISTED
Asensus Surgical, Inc.
ASXC
$42.3K ﹤0.01%
83,765
+45,512
+119% +$27.2K
VBIV
11346
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$41.9K ﹤0.01%
12,725
+5,948
+88% +$18K
CLSD
11347
DELISTED
Clearside Biomedical
CLSD
$41.8K ﹤0.01%
2,489
+77
+3% +$1.33K
ATAI icon
11348
AtaiBeckley Inc
ATAI
$2.74B
$41.7K ﹤0.01%
+24,253
New +$44.6K
TOUR
11349
CALL
Tuniu
TOUR
$52.3M
$41.6K ﹤0.01%
2,520
-2,190
-46% -$35.7K
WKEY
11350
PUT
WISeKey
WKEY
$79.5M
$41.2K ﹤0.01%
9,360
+5,320
+132% +$30.3K

Similar funds

Jeff Yass's Q2 2023 Portfolio in Review

As of Q2 2023, Jeff Yass held 13,811 positions worth $492B, up 4.6% from $470B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jeff Yass's Q2 2023 filing shows 1,371 new, 4,862 increased, 5,559 reduced and 1,866 closed positions. Its largest new stake was State Street SPDR Portfolio Aggregate Bond ETF: 1,297,445 shares worth $32.9M. The largest sale was Invesco QQQ Trust, an estimated $2.48B.

By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 90% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q2 2023 buy was State Street SPDR Portfolio Aggregate Bond ETF: 1,297,445 shares worth $32.9M.
  • Jeff Yass added most to NVIDIA in Q2 2023, an estimated $1.79B increase.
  • Jeff Yass's biggest Q2 2023 reduction was Invesco QQQ Trust, cutting an estimated $2.48B.
  • Jeff Yass fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q2 2023, selling an estimated $45.5M.
  • Jeff Yass's ten largest holdings make up 30% of its $492B portfolio in Q2 2023.
  • Jeff Yass opened 1,371 new positions and closed 1,866 in Q2 2023.
  • Jeff Yass's portfolio value rose 4.6% quarter-over-quarter to $492B.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.